FBR Capital Maintains an 'Outperform' on Healthways (HWAY); Near-Term Investment Mutes 2011 Outlook
Tweet Send to a Friend
FBR Capital maintains an 'Outperform' on Healthways (NASDAQ: HWAY), PT $17.
FBR analyst says, "Our price target represents 13x our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
FBR analyst says, "Our price target represents 13x our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
